M.M. Milinkovic
University of Belgrade
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M.M. Milinkovic.
The International Journal of Neuropsychopharmacology | 2009
Miroslav M. Savić; M.M. Milinkovic; Sundari Rallapalli; Terry Clayton; Srðan Joksimović; Michael L. Van Linn; James M. Cook
The clinical use of benzodiazepines (BZs) is hampered by sedation and cognitive deterioration. Although genetic and pharmacological studies suggest that alpha1- and alpha5-containing GABA(A) receptors mediate and/or modulate these effects, their molecular substrate is not fully elucidated. By the use of two selective ligands: the alpha1-subunit affinity-selective antagonist beta-CCt, and the alpha5-subunit affinity- and efficacy-selective antagonist XLi093, we examined the mechanisms of behavioural effects of diazepam in the tests of spontaneous locomotor activity and water-maze acquisition and recall, the two paradigms indicative of sedative- and cognition-impairing effects of BZs, respectively. The locomotor-activity decreasing propensity of diazepam (significant at 1.5 and 5 mg/kg) was antagonized by beta-CCt (5 and 15 mg/kg), while it tended to be potentiated by XLi093 in doses of 10 mg/kg, and especially 20 mg/kg. Diazepam decreased acquisition and recall in the water maze, with a minimum effective dose of 1.5 mg/kg. Both antagonists reversed the thigmotaxis induced by 2 mg/kg diazepam throughout the test, suggesting that both GABA(A) receptor subtypes participate in BZ effects on the procedural component of the task. Diazepam-induced impairment in the declarative component of the task, as assessed by path efficiency, the latency and distance before finding the platform across acquisition trials, and also by the spatial parameters in the probe trial, was partially prevented by both, 15 mg/kg beta-CCt and 10 mg/kg XLi093. Combining a BZ with beta-CCt results in the near to control level of performance of a cognitive task, without sedation, and may be worth testing on human subjects.
Phytotherapy Research | 2010
Miroslav M. Savić; Jelena Kukić; Renée J. Grayer; M.M. Milinkovic; Petar D. Marin; Jovana Divljaković; Michael L. Van Linn; James M. Cook; Silvana Petrović
We performed a basic behavioral characterization of methanol extracts of four Balkan endemic Stachys taxa: S. anisochila (SA), S. beckeana (SB), S. plumosa (SP) and S. alpina subsp. dinarica (SAD). The behavioral activity of extracts dosed intraperitoneally in the range 100–400 mg/kg was examined in adult male Wistar rats, in the elevated plus maze, spontaneous locomotor activity, and grip strength tests, mainly predictive of anxiolytic, sedative and myorelaxant actions, respectively. All investigated Stachys extracts lacked anxiolytic or myorelaxant activities, while SB at 400 mg/kg exerted an anxiogenic‐like effect. The study with the selective antagonist β‐CCt showed that the sedative effect of SAD was only partially mediated by GABAA receptors containing the α1‐subunit. While discernible, the behavioral effects of SA and SP were not distinct. In all extracts, chlorogenic acid and verbascoside were identified. In SA, SB, and SAD the flavonoid fraction was constituted of isoscutellarein and hypolaetine glycosides, while in SP chrysoeriol and apigenin glycosides were present. The results reveal the psychotropic potential of four endemic Stachys taxa, of which SAD appeared most promising as a natural sedative. Copyright
European Neuropsychopharmacology | 2013
Srđan Joksimović; Jovana Divljaković; Michael L. Van Linn; Zdravko Varagic; Gordana Brajković; M.M. Milinkovic; Wenyuan Yin; Tamara Timić; Werner Sieghart; James M. Cook; Miroslav M. Savić
Despite significant advances in understanding the role of benzodiazepine (BZ)-sensitive populations of GABAA receptors, containing the α1, α2, α3 or α5 subunit, factual substrates of BZ-induced learning and memory deficits are not yet fully elucidated. It was shown that α1-subunit affinity-selective antagonist β-CCt almost completely abolished spatial learning deficits induced by diazepam (DZP) in the Morris water maze. We examined a novel, highly (105 fold) α1-subunit selective ligand-WYS8 (0.2, 1 and 10 mg/kg), on its own and in combination with the non-selective agonist DZP (2 mg/kg) or β-CCt (5 mg/kg) in the water maze in rats. The in vitro efficacy study revealed that WYS8 acts as α1-subtype selective weak partial positive modulator (40% potentiation at 100nM). Measurement of concentrations of WYS8 and DZP in rat serum and brain tissues suggested that they did not substantially cross-influence the respective disposition. In the water maze, DZP impaired spatial learning (acquisition trials) and memory (probe trial). WYS8 caused no effect per se, did not affect the overall influence of DZP on the water-maze performance and was devoid of any activity in this task when combined with β-CCt. Nonetheless, an additional analysis of the latency to reach the platform and the total distance swam suggested that WYS8 addition attenuated the run-down of the spatial impairment induced by DZP at the end of acquisition trials. These results demonstrate a clear difference in the influence of an α1 subtype-selective antagonist and a partial agonist on the effects of DZP on the water-maze acquisition.
Progress in Neuro-psychopharmacology & Biological Psychiatry | 2010
Miroslav M. Savić; Samarpan Majumder; Shengming Huang; Rahul V. Edwankar; Roman Furtmüller; Srđan Joksimović; Terry Clayton; Joachim Ramerstorfer; M.M. Milinkovic; Bryan L. Roth; Werner Sieghart; James M. Cook
European Neuropsychopharmacology | 2012
Srđan Joksimović; Tamara Timić; T. Radulovic; Sundari Rallapalli; M.M. Milinkovic; Jovana Divljaković; Bojan Batinić; James M. Cook; Miroslav M. Savić
European Neuropsychopharmacology | 2011
Jovana Divljaković; M.M. Milinkovic; Tamara Timić; Bojan Batinić; Miroslav M. Savić
European Neuropsychopharmacology | 2010
Srđan Joksimović; S. Huang; J. Ramerstorfer; M.M. Milinkovic; Jovana Divljaković; B.L. Roth; Werner Sieghart; Miroslav M. Savić; James M. Cook
European Neuropsychopharmacology | 2010
Jovana Divljaković; M. Van Linn; M.M. Milinkovic; Wenyuan Yin; B. Batinic; James M. Cook; Miroslav M. Savić
European Neuropsychopharmacology | 2010
M.M. Milinkovic; J. Samardzic; Jovana Divljaković; Srđan Joksimović; Tamara Timić; Miroslav M. Savić
European Neuropsychopharmacology | 2009
Srđan Joksimović; Miroslav M. Savić; M.M. Milinkovic; M. Van Linn; J. Ramerstorfer; S. Majumder; Wenyuan Yin; B.L. Roth; Werner Sieghart; James M. Cook